Abakumov MA - Search Results

1

Assessment of the Parameters of Adaptive Cell-Mediated Immunity in Naïve Common Marmosets (Callithrix jacchus).

Gordeychuk IV, Tukhvatulin AI, Petkov SP, Abakumov MA, Gulyaev SA, Tukhvatulina NM, Gulyaeva TV, Mikhaylov MI, Logunov DY, Isaguliants MG. Gordeychuk IV, et al. Among authors: abakumov ma. Acta Naturae. 2018 Oct-Dec;10(4):63-69. Acta Naturae. 2018. PMID: 30713763 Free PMC article.

2

Luciferase Expression Allows Bioluminescence Imaging But Imposes Limitations on the Orthotopic Mouse (4T1) Model of Breast Cancer.

Baklaushev VP, Kilpeläinen A, Petkov S, Abakumov MA, Grinenko NF, Yusubalieva GM, Latanova AA, Gubskiy IL, Zabozlaev FG, Starodubova ES, Abakumova TO, Isaguliants MG, Chekhonin VP. Baklaushev VP, et al. Among authors: abakumov ma. Sci Rep. 2017 Aug 10;7(1):7715. doi: 10.1038/s41598-017-07851-z. Sci Rep. 2017. PMID: 28798322 Free PMC article.

3

Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity.

Latanova AA, Petkov S, Kilpelainen A, Jansons J, Latyshev OE, Kuzmenko YV, Hinkula J, Abakumov MA, Valuev-Elliston VT, Gomelsky M, Karpov VL, Chiodi F, Wahren B, Logunov DY, Starodubova ES, Isaguliants MG. Latanova AA, et al. Among authors: abakumov ma. Sci Rep. 2018 May 24;8(1):8078. doi: 10.1038/s41598-018-26281-z. Sci Rep. 2018. PMID: 29799015 Free PMC article.

4

Evaluation of cyclic luciferin as a substrate for luminescence measurements in in vitro and in vivo applications.

Abakumov M, Kilpeläinen A, Petkov S, Belikov S, Klyachko N, Chekhonin V, Isaguliants M. Abakumov M, et al. Biochem Biophys Res Commun. 2019 Jun 4;513(3):535-539. doi: 10.1016/j.bbrc.2019.04.006. Epub 2019 Apr 9. Biochem Biophys Res Commun. 2019. PMID: 30979501

5

Expression of the Reverse Transcriptase Domain of Telomerase Reverse Transcriptase Induces Lytic Cellular Response in DNA-Immunized Mice and Limits Tumorigenic and Metastatic Potential of Murine Adenocarcinoma 4T1 Cells.

Jansons J, Bayurova E, Skrastina D, Kurlanda A, Fridrihsone I, Kostyushev D, Kostyusheva A, Artyuhov A, Dashinimaev E, Avdoshina D, Kondrashova A, Valuev-Elliston V, Latyshev O, Eliseeva O, Petkov S, Abakumov M, Hippe L, Kholodnyuk I, Starodubova E, Gorodnicheva T, Ivanov A, Gordeychuk I, Isaguliants M. Jansons J, et al. Vaccines (Basel). 2020 Jun 18;8(2):318. doi: 10.3390/vaccines8020318. Vaccines (Basel). 2020. PMID: 32570805 Free PMC article.

6

Magnetic resonance imaging of endothelial cells with vectorized iron oxide nanoparticles.

Abakumov MA, Goldt AE, Sokolsky-Papkov M, Zorkina YA, Baklaushev VP, Goodilin EA, Kabanov AV, Chekhonin VP. Abakumov MA, et al. Bull Exp Biol Med. 2011 Oct;151(6):726-30. doi: 10.1007/s10517-011-1426-5. Bull Exp Biol Med. 2011. PMID: 22485218

7

Tumor-specific contrast agent based on ferric oxide superparamagnetic nanoparticles for visualization of gliomas by magnetic resonance tomography.

Abakumov MA, Grinenko NF, Baklaushev VP, Sandalova TO, Nukolova NV, Semyonova AV, Sokol'ski-Papkov M, Vishvasrao H, Kabanov AV, Chekhonin VP. Abakumov MA, et al. Bull Exp Biol Med. 2012 May;153(1):89-93. doi: 10.1007/s10517-012-1651-6. Bull Exp Biol Med. 2012. PMID: 22808502

8

Visualization of experimental glioma C6 by MRI with magnetic nanoparticles conjugated with monoclonal antibodies to vascular endothelial growth factor.

Abakumov MA, Shein SA, Vishvasrao H, Nukolova NV, Sokol'ski-Papkov M, Sandalova TO, Gubskii IL, Grinenko NF, Kabanov AV, Chekhonin VP. Abakumov MA, et al. Bull Exp Biol Med. 2012 Dec;154(2):274-7. doi: 10.1007/s10517-012-1929-8. Bull Exp Biol Med. 2012. PMID: 23330142

9

Targeted delivery of cisplatin by сonnexin 43 vector nanogels to the focus of experimental glioma C6.

Nukolova NV, Baklaushev VP, Abakumova TO, Mel'nikov PA, Abakumov MA, Yusubalieva GM, Bychkov DA, Kabanov AV, Chekhonin VP. Nukolova NV, et al. Among authors: abakumov ma. Bull Exp Biol Med. 2014 Aug;157(4):524-9. doi: 10.1007/s10517-014-2606-x. Epub 2014 Aug 12. Bull Exp Biol Med. 2014. PMID: 25110098

10

VEGF-targeted magnetic nanoparticles for MRI visualization of brain tumor.

Abakumov MA, Nukolova NV, Sokolsky-Papkov M, Shein SA, Sandalova TO, Vishwasrao HM, Grinenko NF, Gubsky IL, Abakumov AM, Kabanov AV, Chekhonin VP. Abakumov MA, et al. Among authors: abakumov am. Nanomedicine. 2015 May;11(4):825-33. doi: 10.1016/j.nano.2014.12.011. Epub 2015 Jan 31. Nanomedicine. 2015. PMID: 25652902

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page